SOD1 and amyotrophic lateral sclerosis: This aimed to reduce the burden of extracellular SOD1 and has provided therapeutic benefits in ALS mice.186,187 From a therapeutic point of view, the discovery of prionoid spreading in people with ALS opens perspectives that cover a large number of pathways.